{
    "root": "2f83d789-5194-ffd6-e063-6394a90acb8e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "RALDESY",
        "suffix": {
            "text": "TM"
        }
    },
    "value": "20250304",
    "ingredients": [
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "PROPYL GALLATE",
            "code": "8D4SNN7V92"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "PHOSPHORIC ACID",
            "code": "E4GA8884NN"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "TRAZODONE HYDROCHLORIDE",
            "code": "6E8ZO8LRNM"
        }
    ],
    "indications": "RALDESY\n \n  TMis indicated for the treatment of major depressive disorder (MDD) in adults.",
    "contraindications": "Starting dosage: 150 mg orally in divided doses daily. May be increased by 50 mg per day every three to four days. Maximum dosage: 400 mg per day in divided doses ( 2.1 ). Administer RALDESY shortly after a meal or light snack ( 2.1 ). When discontinuing RALDESY, gradually reduce dose ( 2.5 ).",
    "warningsAndPrecautions": "How Supplied\n                       RALDESY\n \n  TMcontains 10 mg/mL of trazodone hydrochloride. It is a clear, colorless solution and is supplied as:\n\n \n                  150 mL amber glass bottle\n                  \n                     NDC 30698-455-03 with child-resistant cap along with a 10 mL calibrated oral dosing syringe and bottle adapter.\n                  \n                  150 mL white, opaque, high-density polyethylene (HDPE) bottle\n                  \n                     NDC 30698-455-02 with child-resistant cap along with a 10 mL calibrated oral dosing syringe and bottle adapter.\n                  \n                  300 mL amber glass bottle\n                  \n                     NDC 30698-455-04 with child-resistant cap along with a 10 mL calibrated oral dosing syringe and bottle adapter.\n                  \n                  300 mL white, opaque, HDPE bottle\n                  \n                     NDC 30698-455-01 with child-resistant cap along with a 10 mL calibrated oral dosing syringe and bottle adapter.\n                  \n                  The bottle, bottle adapter and the dosing syringe are placed in a carton.\n                  \n                     Storage and Handling\n                     \n                     Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. \n    Protect from light. Discard any unused RALDESY remaining in the bottle 30 days after first opening the bottle.",
    "adverseReactions": "RALDESY is contraindicated in patients taking, or within 14 days of stopping, monoamine oxidase inhibitors (MAOIs), including MAOIs such as linezolid or intravenous methylene blue, because of an increased risk of serotonin syndrome \n \n  [see\n  \n   Warnings and Precautions (5.2),\n  \n   Drug Interactions (7.1)]."
}